Activation of Endocannabinoid System Is Associated with Persistent Inflammation in Human Aortic Aneurysm
Table 2
Surgery and postoperative patient data.
CAD
CAD subgroups
AAA
Total
Histology
PCR
LC-MRM
Aortic prosthesis (%)
0.00
0.00
0.00
0.00
100.00
(0/73)
(0/24)
(0/30)
(0/25)
Aortic valve replacement (%)
15.07
16.67
13.33
12
42.10
(11/73)
(4/24)
(4/30)
(3/25)
(8/19)
Aortic valve repair (%)
0.00
0.00
0.00
0.00
15.79
(0/73)
(0/24)
(0/30)
(0/25)
(3/19)
CABG surgery (%)
100
100
100
100
10.50
(73/73)
(24/24)
(30/30)
(25/25)
(2/19)
Perioperative stroke (%)
0.00
0.00
0.00
0.00
0.00
(0/73)
(0/24)
(0/30)
(0/25)
(0/19)
Hemoglobin (g/dL)
10.48 ± 0.16
10.64 ± 0.29
10.33 ± 0.25
10.59 ± 0.24
10.84 ± 0.31
Creatinine (mg/dL)
1.15 ± 0.04
1.02 ± 0.07
1.17 ± 0.08
1.21 ± 0.09
1.01 ± 0.07
Troponin (ng/dL)
0.68 ± 0.22
0.43 ± 1.11
0.96 ± 0.47
0.73 ± 0.44
1.09 ± 0.34
WBC count (G/L)
9.64 ± 0.30
10.26 ± 0.56
9.44 ± 0.36
9.34 ± 0.61
9.47 ± 0.87
CRP (mg/L)
70.84 ± 6.00
70.3 ± 11.7
68.00 ± 8.33
69.59 ± 9.53
80.53 ± 9.36
Surgery data and laboratory data obtained 72 h postoperatively. Normal range of laboratory parameters are creatinine 0.6–1.3 mg/dL, troponin <0.05 ng/mL, haemoglobin 12.0–15.4 g/dL, WBC count 3.9–10.2 G/L, and CRP < 3 mg/L. CAD: coronary artery disease, AAA: aneurysm of ascending aorta, CABG: coronary artery bypass grafting, WBC: white blood cell, and CRP: C-reactive protein. Data presented as mean ± SEM. versus AAA.
